CRAI vs HURN vs FTI vs EXPO vs FORR

For growth investors, Huron Consulting Group Inc.

(HURN) is the stronger pick with 14. 3% revenue growth year-over-year, versus -8. 2% for Forrester Research, Inc. (FORR). CRA International, Inc. (CRAI) offers the better valuation at 17. 1x trailing P/E (16. 9x forward), making it the more compelling value choice. Analysts rate CRA International, Inc. (CRAI) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, CRA International, Inc.

(CRAI) is the cheapest at 17. 1x versus TechnipFMC plc at 30. 9x. On forward P/E, Forrester Research, Inc. is actually cheaper at 8. 5x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: CRA International, Inc. wins at 0. 78x versus Exponent, Inc. 's 5. 18x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, TechnipFMC plc (FTI) delivered a total return of +734.

4%, compared to -85. 9% for Forrester Research, Inc. (FORR). Over 10 years, the gap is even starker: CRAI returned +550. 5% versus FORR's -75. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), TechnipFMC plc (FTI) is the lower-risk stock at 0.

59β versus Exponent, Inc. 's 0. 89β — meaning EXPO is approximately 50% more volatile than FTI relative to the S&P 500. On balance sheet safety, Exponent, Inc. (EXPO) carries a lower debt/equity ratio of 21% versus 104% for Huron Consulting Group Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Huron Consulting Group Inc.

(HURN) is pulling ahead at 14. 3% versus -8. 2% for Forrester Research, Inc. (FORR). On earnings-per-share growth, the picture is similar: CRA International, Inc. grew EPS 20. 8% year-over-year, compared to -1993. 3% for Forrester Research, Inc.. Over a 3-year CAGR, HURN leads at 14. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Exponent, Inc.

(EXPO) is the more profitable company, earning 18. 2% net margin versus -30. 1% for Forrester Research, Inc. — meaning it keeps 18. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EXPO leads at 20. 6% versus 0. 5% for FORR. At the gross margin level — before operating expenses — FORR leads at 53. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, CRA International, Inc. (CRAI) is the more undervalued stock at a PEG of 0. 78x versus Exponent, Inc. 's 5. 18x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Forrester Research, Inc. (FORR) trades at 8. 5x forward P/E versus 30. 9x for Exponent, Inc. — 22. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HURN: 60. 3% to $200. 00.

In this comparison, EXPO (1.

9% yield), CRAI (1. 5% yield), FTI (0. 3% yield) pay a dividend. HURN, FORR do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, CRA International, Inc.

(CRAI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 73), 1. 5% yield, +550. 5% 10Y return). Both have compounded well over 10 years (CRAI: +550. 5%, FORR: -75. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (CRAI (Industrials) and HURN (Industrials) and FTI (Energy) and EXPO (Industrials) and FORR (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: CRAI is a small-cap deep-value stock; HURN is a small-cap quality compounder stock; FTI is a mid-cap quality compounder stock; EXPO is a small-cap quality compounder stock; FORR is a small-cap quality compounder stock. CRAI, EXPO pay a dividend while HURN, FTI, FORR do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.